Breast cancer
Results
Phase 3
This study was trying to find out more about the heart problems that can be caused by having epirubicin as treatment for breast cancer.
Recruitment start: 1 June 2005
Recruitment end: 31 May 2009
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Hugh Montgomery
Department of Health
Experimental Cancer Medicine Centre (ECMC)
Imperial College London
University College London (UCL)
NIHR Clinical Research Network: Cancer
Last reviewed: 11 July 2013
CRUK internal database number: 753
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
